Finding mechanisms from metabolic signatures of disease by Newgard, Christopher B
ORAL PRESENTATION Open Access
Finding mechanisms from metabolic signatures
of disease
Christopher B Newgard
From Metabolism, diet and disease
Washington, DC, USA. 29-31 May 2012
We seek to apply comprehensive metabolic analysis tools
(sometimes called “metabolomics”) for understanding of
mechanisms underlying chronic human diseases and con-
ditions such as diabetes, obesity, and cardiovascular
disease. Current approaches include analysis of metabolic
flux by
13C NMR-based mass isotopomer analysis (in col-
laboration with Drs. Shawn Burgess and A. Dean Sherry
and associates, Dallas, TX) and metabolic profiling of
important groups of metabolic intermediates by both “tar-
geted” and “unbiased” mass spectrometry (in collaboration
with Drs. James Bain, Robert Stevens, Olga llkayeva, Brett
Wenner, Michael Muehlbauer, Mark Butler, and David
Millington at Duke). These tools have also been used to
define mechanisms underlying development of peripheral
insulin resistance in animals and humans. For example, we
have recently identified perturbations of branched chain
amino acid (BCAA) catabolism in multiple cohorts of
insulin resistant humans compared to normally insulin
sensitive controls and have translated these findings to
rodent models to demonstrate a contribution of BCAA to
development of insulin resistance that is independent of
body weight. In collaboration with Dr. Alan Attie at the
University of Wisconsin, we have integrated transcrip-
tomic and metabolomic analysis in mouse models to iden-
tify new pathways that control hepatic gluconeogenesis
and PEPCK expression. Finally, with Svati Shah and Bill
Kraus at Duke, we have identified novel metabolic signa-
tures of imminent cardiovascular events, and are integrat-
ing genomic and metabolomics analyses in large cohorts
of human subjects with a high incidence of coronary artery
disease to identify pathways involved in metabolic variabil-
ity and risk of cardiovascular disease. These examples will
serve to illustrate the potential of comprehensive
metabolic profiling methods for providing insights into
metabolic disease mechanisms.
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